GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pro Medicus PME.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

205.49

+0.18%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Pro Medicus

Its shares trade on ASX under the ticker PME.AX. It has been listed since 10 October 2000. In the fiscal year to 30 June 2026, it reported revenue of A$261.7m and net income of A$265.3m. At that date it held total assets of A$610.1m and shareholders' equity of A$450.9m.

Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. The company is headquartered in Richmond, Victoria. The company went IPO on 2000-10-10. The firm provides a range of health imaging software and services to hospitals, imaging centers and health care groups. The company offers its solutions under the brand, Visage. Its segments include Australia, Europe and North America. The Visage product line comprises solutions for radiology information systems (RIS)/practice management, healthcare imaging and e-health. These systems can be used either individually or in combination by radiologists and other medical imaging professionals to interpret the images created by medical imaging equipment, such as X-Ray and Ultrasound machines and computed tomography (CT) and magnetic resonance imaging (MRI) scanners and communicate the results to their referring clinicians. Its products include Visage RIS, Visage 7, Visage Ease Pro and Visage Ease.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Technology
Listed since
10 Oct 2000
Employees
79

Leadership

Pay as last reported

  • Mr. Peter KempenNon-Executive Independent Chairman of the BoardA$250,000
  • Dr. Sam HupertChief Executive Officer, Managing Director, Executive Director, since 2010A$965,221
  • Mr. Clayton HatchChief Financial OfficerA$500,773
  • Mr. Malte WesterhoffGeneral Manager Europe and Global Chief Technology OfficerA$1.6m
  • Mr. Brad LevinGeneral Manager - North America and Global Head of MarketingA$401,248
  • Mr. Danny TauberGeneral Manager - Australia, since 2011A$423,573
  • Mr. Anthony HallTechnology Director, Executive DirectorA$373,261
  • Ms. Teresa GschwindGlobal Head - Customer Service
  • Mr. Sean LambrightGlobal Head of Sales - Visage Imaging IncA$1.2m
  • Ms. Sharni RedenbachPeople and Culture Director
  • Ms. Danny EnglishCompany Secretary
  • Dr. Leigh FarrellNon-Executive Independent DirectorA$125,000

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
34
Environment
45
Social
36
Governance
23
Direct emissions (scope 1)
1.9 t
Energy emissions (scope 2)
118.9 t
Women in the workforce
26.7%
Carbon reduction policy
No
Human rights policy
No

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Pro Medicus Ltd has several key strengths:

Weaknesses

  • Pro Medicus Ltd also faces certain weaknesses:

Opportunities

  • Pro Medicus Ltd should consider the following opportunities:

Threats

  • Pro Medicus Ltd should be aware of potential threats:

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.